chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of SINUS CONGESTION (sinus congestion), VACCINATION SITE PRURITUS (injection site reaction with itching, redness, and swelling about walnut size), FATIGUE (felt tired), MYALGIA (achy all over) and VACCINATION SITE ERYTHEMA (injection site reaction with itching, redness, and swelling about walnut size) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Fatigue (fatigued and depressed as her mother had passed away on 21DEC2020), Depressed state and Surgery on 07-Dec-2020. Concurrent medical conditions included UTI and Blood pressure high. Concomitant products included VALSARTAN for Blood pressure high, LEVOTHYROXINE and SIMVASTATIN. On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced VACCINATION SITE PRURITUS (injection site reaction with itching, redness, and swelling about walnut size), FATIGUE (felt tired), MYALGIA (achy all over), VACCINATION SITE ERYTHEMA (injection site reaction with itching, redness, and swelling about walnut size) and VACCINATION SITE SWELLING (injection site reaction with itching, redness, and swelling about walnut size). On an unknown date, the patient experienced SINUS CONGESTION (sinus congestion). On 02-Jan-2021, VACCINATION SITE PRURITUS (injection site reaction with itching, redness, and swelling about walnut size), FATIGUE (felt tired), MYALGIA (achy all over), VACCINATION SITE ERYTHEMA (injection site reaction with itching, redness, and swelling about walnut size) and VACCINATION SITE SWELLING (injection site reaction with itching, redness, and swelling about walnut size) had resolved. At the time of the report, SINUS CONGESTION (sinus congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided as such but the patient stopped taking Simvastatin and Antibiotics.   This case was linked to MOD-2021-020998 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: My lymph nodes under my arm pit are very swollen and painful (same arm of injection); My lymph nodes under my arm pit are very swollen and painful (same arm of injection); This spontaneous case was reported by a consumer and describes the occurrence of the first episode of LYMPHADENOPATHY (My lymph nodes under my arm pit are very swollen and painful (same arm of injection)) and the second episode of LYMPHADENOPATHY (My lymph nodes under my arm pit are very swollen and painful (same arm of injection)) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced the first episode of LYMPHADENOPATHY (My lymph nodes under my arm pit are very swollen and painful (same arm of injection)) and the second episode of LYMPHADENOPATHY (My lymph nodes under my arm pit are very swollen and painful (same arm of injection)). At the time of the report, last episode of LYMPHADENOPATHY (My lymph nodes under my arm pit are very swollen and painful (same arm of injection)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Tinnitus
Clinical narrative: Making it difficult for her to go about her daily life; Ringing in the head one day after first dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in the head one day after first dose of Moderna vaccine) and MALAISE (Making it difficult for her to go about her daily life) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Psychiatric disorder NOS. Concomitant products included PALIPERIDONE PALMITATE (INVEGA SUSTENNA), METFORMIN, GLIPIZIDE, SIMVASTATIN and SITAGLIPTIN PHOSPHATE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced TINNITUS (Ringing in the head one day after first dose of Moderna vaccine). On an unknown date, the patient experienced MALAISE (Making it difficult for her to go about her daily life). At the time of the report, TINNITUS (Ringing in the head one day after first dose of Moderna vaccine) and MALAISE (Making it difficult for her to go about her daily life) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up information received on 11-May-2021 contains significant information: updated information of dosage route of administration and also updated reporter's address.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient went to the pharmacy to receive the second vaccine dose, and it is been 2 months since the patient received the first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient went to the pharmacy to receive the second vaccine dose, and it is been 2 months since the patient received the first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient went to the pharmacy to receive the second vaccine dose, and it is been 2 months since the patient received the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient went to the pharmacy to receive the second vaccine dose, and it is been 2 months since the patient received the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of Inappropriate schedule of product administration for mRNA-1273, lot # unknown, with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Limb discomfort, Myalgia, Pain in extremity
Clinical narrative: Muscle pain; Joint pain; Diarrhoea; Continued injection arm symptoms; Bad aches in both arms; Arm of injection really hurts; Arm of injection feels heavy; Palpitations in chest (resolved now); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Bad aches in both arms), PAIN IN EXTREMITY (Arm of injection really hurts), LIMB DISCOMFORT (Arm of injection feels heavy), PALPITATIONS (Palpitations in chest (resolved now)) and MYALGIA (Muscle pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included TRAMADOL, IRON and VITAMINS WITH MINERALS for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Bad aches in both arms), PAIN IN EXTREMITY (Arm of injection really hurts), LIMB DISCOMFORT (Arm of injection feels heavy) and PALPITATIONS (Palpitations in chest (resolved now)). On 09-Apr-2021, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), DIARRHOEA (Diarrhoea) and VACCINATION SITE REACTION (Continued injection arm symptoms). At the time of the report, PAIN IN EXTREMITY (Bad aches in both arms), PAIN IN EXTREMITY (Arm of injection really hurts), LIMB DISCOMFORT (Arm of injection feels heavy), PALPITATIONS (Palpitations in chest (resolved now)), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), DIARRHOEA (Diarrhoea) and VACCINATION SITE REACTION (Continued injection arm symptoms) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-072819 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-072819:First dose case
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Vaccination site reaction
Clinical narrative: Muscle pain; Joint pain; Diarrhoea; Continued injection arm symptoms; Bad aches in both arms; Arm of injection really hurts; Arm of injection feels heavy; Palpitations in chest (resolved now); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Bad aches in both arms), PAIN IN EXTREMITY (Arm of injection really hurts), LIMB DISCOMFORT (Arm of injection feels heavy), PALPITATIONS (Palpitations in chest (resolved now)) and MYALGIA (Muscle pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included TRAMADOL, IRON and VITAMINS WITH MINERALS for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Bad aches in both arms), PAIN IN EXTREMITY (Arm of injection really hurts), LIMB DISCOMFORT (Arm of injection feels heavy) and PALPITATIONS (Palpitations in chest (resolved now)). On 09-Apr-2021, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), DIARRHOEA (Diarrhoea) and VACCINATION SITE REACTION (Continued injection arm symptoms). At the time of the report, PAIN IN EXTREMITY (Bad aches in both arms), PAIN IN EXTREMITY (Arm of injection really hurts), LIMB DISCOMFORT (Arm of injection feels heavy), PALPITATIONS (Palpitations in chest (resolved now)), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), DIARRHOEA (Diarrhoea) and VACCINATION SITE REACTION (Continued injection arm symptoms) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-072819 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-072819:First dose case
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Cough, Fatigue, Pain
Clinical narrative: body aches; little bit of a sniffly nose; dry cough; loss of taste and smell; loss of taste and smell; was a little tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), RHINORRHOEA (little bit of a sniffly nose), COUGH (dry cough), AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN D NOS, ZINC and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021, the patient experienced PAIN (body aches), RHINORRHOEA (little bit of a sniffly nose), COUGH (dry cough), AGEUSIA (loss of taste and smell), ANOSMIA (loss of taste and smell) and FATIGUE (was a little tired). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] ongoing since an unknown date for Pain, at a dose of UNK dosage form. At the time of the report, PAIN (body aches), RHINORRHOEA (little bit of a sniffly nose), COUGH (dry cough), AGEUSIA (loss of taste and smell), ANOSMIA (loss of taste and smell) and FATIGUE (was a little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Aspirin was given as treatment medication   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: body aches; little bit of a sniffly nose; dry cough; loss of taste and smell; loss of taste and smell; was a little tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), RHINORRHOEA (little bit of a sniffly nose), COUGH (dry cough), AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN D NOS, ZINC and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021, the patient experienced PAIN (body aches), RHINORRHOEA (little bit of a sniffly nose), COUGH (dry cough), AGEUSIA (loss of taste and smell), ANOSMIA (loss of taste and smell) and FATIGUE (was a little tired). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] ongoing since an unknown date for Pain, at a dose of UNK dosage form. At the time of the report, PAIN (body aches), RHINORRHOEA (little bit of a sniffly nose), COUGH (dry cough), AGEUSIA (loss of taste and smell), ANOSMIA (loss of taste and smell) and FATIGUE (was a little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Aspirin was given as treatment medication   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Pain in extremity, Product dose omission issue, Urinary tract infection, Urticaria
Clinical narrative: She was sick after two week; urinary tract infection; hives; She missed her 2nd dose which was due on 31st March; Soreness of left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of left arm), ILLNESS (She was sick after two week), URINARY TRACT INFECTION (urinary tract infection), URTICARIA (hives) and PRODUCT DOSE OMISSION ISSUE (She missed her 2nd dose which was due on 31st March) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness of left arm) and PRODUCT DOSE OMISSION ISSUE (She missed her 2nd dose which was due on 31st March). On an unknown date, the patient experienced ILLNESS (She was sick after two week), URINARY TRACT INFECTION (urinary tract infection) and URTICARIA (hives). At the time of the report, PAIN IN EXTREMITY (Soreness of left arm), URINARY TRACT INFECTION (urinary tract infection), URTICARIA (hives) and PRODUCT DOSE OMISSION ISSUE (She missed her 2nd dose which was due on 31st March) outcome was unknown and ILLNESS (She was sick after two week) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication information not provided. Treatment medication include Antibiotics, Bactrim DS.
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Feeling abnormal, Gait disturbance, Insomnia, Muscular weakness
Clinical narrative: Not gotten a good night's sleep; Sore and achy all over; Feels unstable; Very uncomfortable; Having difficulty walking; Weakness in her legs; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Having difficulty walking), MUSCULAR WEAKNESS (Weakness in her legs), INSOMNIA (Not gotten a good night's sleep), FEELING ABNORMAL (Feels unstable) and DISCOMFORT (Very uncomfortable) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced GAIT DISTURBANCE (Having difficulty walking), MUSCULAR WEAKNESS (Weakness in her legs), FEELING ABNORMAL (Feels unstable) and DISCOMFORT (Very uncomfortable). On 05-Apr-2021, the patient experienced INSOMNIA (Not gotten a good night's sleep) and MYALGIA (Sore and achy all over). At the time of the report, GAIT DISTURBANCE (Having difficulty walking), MUSCULAR WEAKNESS (Weakness in her legs), INSOMNIA (Not gotten a good night's sleep), FEELING ABNORMAL (Feels unstable), DISCOMFORT (Very uncomfortable) and MYALGIA (Sore and achy all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  The patient started using her cane again for stability.  Treatment information was not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up received on 12-May-2021 contains non-significant information: added reporters address.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Not gotten a good night's sleep; Sore and achy all over; Feels unstable; Very uncomfortable; Having difficulty walking; Weakness in her legs; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Having difficulty walking), MUSCULAR WEAKNESS (Weakness in her legs), INSOMNIA (Not gotten a good night's sleep), FEELING ABNORMAL (Feels unstable) and DISCOMFORT (Very uncomfortable) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced GAIT DISTURBANCE (Having difficulty walking), MUSCULAR WEAKNESS (Weakness in her legs), FEELING ABNORMAL (Feels unstable) and DISCOMFORT (Very uncomfortable). On 05-Apr-2021, the patient experienced INSOMNIA (Not gotten a good night's sleep) and MYALGIA (Sore and achy all over). At the time of the report, GAIT DISTURBANCE (Having difficulty walking), MUSCULAR WEAKNESS (Weakness in her legs), INSOMNIA (Not gotten a good night's sleep), FEELING ABNORMAL (Feels unstable), DISCOMFORT (Very uncomfortable) and MYALGIA (Sore and achy all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  The patient started using her cane again for stability.  Treatment information was not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up received on 12-May-2021 contains non-significant information: added reporters address.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itching; got a rash on the arm of the injection and is spreading on her chest, neck and back; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a health care professional and describes the occurrence of PRURITUS (itching) and RASH (got a rash on the arm of the injection and is spreading on her chest, neck and back) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (allergic to, aluminum, latex, feathers, clorine, pine, lavender, peppermint, nuts (all kinds).), Drug allergy (allergic to, aluminum, latex, feathers, clorine, pine, lavender, peppermint, nuts (all kinds).) and Food allergy (allergic to, aluminum, latex, feathers, clorine, pine, lavender, peppermint, nuts (all kinds).). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PRURITUS (itching) and RASH (got a rash on the arm of the injection and is spreading on her chest, neck and back). At the time of the report, PRURITUS (itching) and RASH (got a rash on the arm of the injection and is spreading on her chest, neck and back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drug includes herbs. Treatment medication includes put Alevila on it.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Potentiating drug interaction, Product dose omission issue
Clinical narrative: Potentiating drug interaction; didn't get her shot, she didn'tthink it was worth the risk; her fingers are killing her; This spontaneous case was reported by a consumer and describes the occurrence of POTENTIATING DRUG INTERACTION (Potentiating drug interaction), PRODUCT DOSE OMISSION ISSUE (didn't get her shot, she didn'tthink it was worth the risk) and PAIN IN EXTREMITY (her fingers are killing her) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced POTENTIATING DRUG INTERACTION (Potentiating drug interaction), PRODUCT DOSE OMISSION ISSUE (didn't get her shot, she didn'tthink it was worth the risk) and PAIN IN EXTREMITY (her fingers are killing her). At the time of the report, POTENTIATING DRUG INTERACTION (Potentiating drug interaction), PRODUCT DOSE OMISSION ISSUE (didn't get her shot, she didn'tthink it was worth the risk) and PAIN IN EXTREMITY (her fingers are killing her) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       NO concomitant medication details were provided. No treatment medication details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Dyskinesia, Influenza
Clinical narrative: chills; fever of 102 degrees F; coughing; nose running; extremely lethargic; couldn't eat last night; arm was killing her- shoulder at injection site; hard time lifting left arm; felt like had the flu for 18 hours; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever of 102 degrees F), COUGH (coughing), RHINORRHOEA (nose running) and LETHARGY (extremely lethargic) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Apr-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 102 degrees F), COUGH (coughing), RHINORRHOEA (nose running), LETHARGY (extremely lethargic), DECREASED APPETITE (couldn't eat last night), VACCINATION SITE PAIN (arm was killing her- shoulder at injection site), DYSKINESIA (hard time lifting left arm) and INFLUENZA (felt like had the flu for 18 hours).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment Tylenol every 4 hours, and drank lots of water
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Pyrexia, Rhinorrhoea, Vaccination site pain
Clinical narrative: chills; fever of 102 degrees F; coughing; nose running; extremely lethargic; couldn't eat last night; arm was killing her- shoulder at injection site; hard time lifting left arm; felt like had the flu for 18 hours; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever of 102 degrees F), COUGH (coughing), RHINORRHOEA (nose running) and LETHARGY (extremely lethargic) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Apr-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 102 degrees F), COUGH (coughing), RHINORRHOEA (nose running), LETHARGY (extremely lethargic), DECREASED APPETITE (couldn't eat last night), VACCINATION SITE PAIN (arm was killing her- shoulder at injection site), DYSKINESIA (hard time lifting left arm) and INFLUENZA (felt like had the flu for 18 hours).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment Tylenol every 4 hours, and drank lots of water
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Headache, Pain in extremity
Clinical narrative: Chills; Headache; soreness in injection arm and pectoral muscle; soreness in injection arm and pectoral muscle; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in injection arm and pectoral muscle), CHEST PAIN (soreness in injection arm and pectoral muscle), CHILLS (Chills) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026b21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in injection arm and pectoral muscle) and CHEST PAIN (soreness in injection arm and pectoral muscle). On 03-Apr-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). On 03-Apr-2021, PAIN IN EXTREMITY (soreness in injection arm and pectoral muscle) and CHEST PAIN (soreness in injection arm and pectoral muscle) had resolved. On 04-Apr-2021, CHILLS (Chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus, Vaccination site induration
Clinical narrative: arm swollen; arm red; arm itchy; Felt hardness, like she's been stung by a bee; arm painful; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swollen), ERYTHEMA (arm red), PRURITUS (arm itchy), VACCINATION SITE INDURATION (Felt hardness, like she's been stung by a bee) and PAIN IN EXTREMITY (arm painful) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm swollen), ERYTHEMA (arm red), PRURITUS (arm itchy), VACCINATION SITE INDURATION (Felt hardness, like she's been stung by a bee) and PAIN IN EXTREMITY (arm painful). At the time of the report, PERIPHERAL SWELLING (arm swollen), ERYTHEMA (arm red), PRURITUS (arm itchy), VACCINATION SITE INDURATION (Felt hardness, like she's been stung by a bee) and PAIN IN EXTREMITY (arm painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm after first vaccination; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm after first vaccination) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 019B21A) for COVID-19 vaccination.     The patient's past medical history included Cardioversion (has had no issues with arrhythmias since procedure in 2019) in 2019. Concurrent medical conditions included AFib. Concomitant products included LOSARTAN, ATORVASTATIN, FLECAINIDE, FUROSEMIDE (LASIX [FUROSEMIDE]) and POTASSIUM for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm after first vaccination). On 08-Mar-2021, VACCINATION SITE PAIN (Sore arm after first vaccination) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pyrexia
Clinical narrative: stayed in bed for three days; chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (stayed in bed for three days), CHILLS (chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (stayed in bed for three days), CHILLS (chills) and PYREXIA (Fever). At the time of the report, MALAISE (stayed in bed for three days), CHILLS (chills) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history or concomitant medications provided. No treatment details were reported.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Contusion, Epistaxis
Clinical narrative: Blood under skin on right ankle; Under his right ankle inside of foot start bruising; Nose started bleeding; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONTUSION (Blood under skin on right ankle), EPISTAXIS (Nose started bleeding) and CONTUSION (Under his right ankle inside of foot start bruising) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ZINC and ASCORBIC ACID (VIT C) for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EPISTAXIS (Nose started bleeding). On 08-Apr-2021, the patient experienced CONTUSION (Blood under skin on right ankle) and CONTUSION (Under his right ankle inside of foot start bruising). At the time of the report, CONTUSION (Blood under skin on right ankle), EPISTAXIS (Nose started bleeding) and CONTUSION (Under his right ankle inside of foot start bruising) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: unknown unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Description: The patient reported that 20 minutes after first dose, his nose started bleeding. The patient stated that on 08 Apr 2021, under his right ankle inside of foot started bruising and had blood under skin.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Stomach diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Stomach diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder NOS.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Stomach diarrhea). At the time of the report, DIARRHOEA (Stomach diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported. The reporter reported that her friend received Moderna vaccine and she experienced stomach diarrhea as one of the side effects, which lasts longer than they expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Flu like symptoms; rash is warm to touch; itching; rash the day of the vaccination just above the injection site and slight arm soreness; rash the day of the vaccination just above the injection site and slight arm soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE WARMTH (rash is warm to touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE RASH (rash the day of the vaccination just above the injection site and slight arm soreness) and VACCINATION SITE PAIN (rash the day of the vaccination just above the injection site and slight arm soreness) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE RASH (rash the day of the vaccination just above the injection site and slight arm soreness) and VACCINATION SITE PAIN (rash the day of the vaccination just above the injection site and slight arm soreness). On 09-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE WARMTH (rash is warm to touch) and VACCINATION SITE PRURITUS (itching). On 02-Apr-2021, VACCINATION SITE RASH (rash the day of the vaccination just above the injection site and slight arm soreness) and VACCINATION SITE PAIN (rash the day of the vaccination just above the injection site and slight arm soreness) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE WARMTH (rash is warm to touch) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided.  Additional information: She had a rash the day of the vaccination just above the injection site and slight arm soreness which went away after a day. On 09APR2021 she developed a much larger rash in the same area as before which arm soreness. The rash is very itchy and warm to touch. She also has flu-like symptoms
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Myalgia, Pyrexia
Clinical narrative: Feel like crying; chills; fever of 100.6°F; Fatigue; Body ache; Arm was sore where they gave me the shot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feel like crying), CHILLS (chills), PYREXIA (fever of 100.6°F), FATIGUE (Fatigue) and MYALGIA (Body ache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Melanoma. Concurrent medical conditions included Trigeminal neuralgia, Anemia, Disability and Palpitations.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 100.6°F), FATIGUE (Fatigue), MYALGIA (Body ache) and VACCINATION SITE PAIN (Arm was sore where they gave me the shot). On an unknown date, the patient experienced FEELING ABNORMAL (Feel like crying). The patient was treated with PARACETAMOL (TYLENOL ARTHRITIS) at a dose of 1 dosage form every four hours. At the time of the report, FEELING ABNORMAL (Feel like crying), CHILLS (chills), PYREXIA (fever of 100.6°F), FATIGUE (Fatigue), MYALGIA (Body ache) and VACCINATION SITE PAIN (Arm was sore where they gave me the shot) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant drug was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Event outcome updated to resolved.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Feel like crying; chills; fever of 100.6°F; Fatigue; Body ache; Arm was sore where they gave me the shot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feel like crying), CHILLS (chills), PYREXIA (fever of 100.6°F), FATIGUE (Fatigue) and MYALGIA (Body ache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Melanoma. Concurrent medical conditions included Trigeminal neuralgia, Anemia, Disability and Palpitations.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 100.6°F), FATIGUE (Fatigue), MYALGIA (Body ache) and VACCINATION SITE PAIN (Arm was sore where they gave me the shot). On an unknown date, the patient experienced FEELING ABNORMAL (Feel like crying). The patient was treated with PARACETAMOL (TYLENOL ARTHRITIS) at a dose of 1 dosage form every four hours. At the time of the report, FEELING ABNORMAL (Feel like crying), CHILLS (chills), PYREXIA (fever of 100.6°F), FATIGUE (Fatigue), MYALGIA (Body ache) and VACCINATION SITE PAIN (Arm was sore where they gave me the shot) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant drug was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Event outcome updated to resolved.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site pain, Myalgia, Pyrexia
Clinical narrative: generalized muscle pain; tenderness at injection site; fever; Pain at injection site; headache; Generalized join pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (generalized muscle pain), INJECTION SITE PAIN (tenderness at injection site), PYREXIA (fever), INJECTION SITE PAIN (Pain at injection site) and HEADACHE (headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lymphoma. Concomitant products included APOAEQUORIN, COLECALCIFEROL (PREVAGEN [APOAEQUORIN;COLECALCIFEROL]), PHENYTOIN SODIUM (DILANTIN D.A.), LISINOPRIL, MELOXICAM, OMEPRAZOLE, AMLODIPINE, PRAVASTATIN, APREMILAST (OTEZLA), ONDANSETRON, CALCIPOTRIENE, MECLIZINE HCL and CITALOPRAM.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 08-Apr-2021, the patient experienced MYALGIA (generalized muscle pain), INJECTION SITE PAIN (tenderness at injection site), PYREXIA (fever), INJECTION SITE PAIN (Pain at injection site), HEADACHE (headache) and ARTHRALGIA (Generalized join pain). At the time of the report, MYALGIA (generalized muscle pain), INJECTION SITE PAIN (tenderness at injection site), PYREXIA (fever), INJECTION SITE PAIN (Pain at injection site), HEADACHE (headache) and ARTHRALGIA (Generalized join pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: pain at the injection site; Rash on left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on left arm) and VACCINATION SITE PAIN (pain at the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE RASH (Rash on left arm). On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE RASH (Rash on left arm) and VACCINATION SITE PAIN (pain at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included allergy medicines. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Outcome of the event was updated.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Inappropriate schedule of product administration, Pruritus
Clinical narrative: itchiness; Reaction; Received first dose in 25Feb2021; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), HYPERSENSITIVITY (Reaction) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose in 25Feb2021) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose in 25Feb2021). On an unknown date, the patient experienced PRURITUS (itchiness) and HYPERSENSITIVITY (Reaction). On 09-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose in 25Feb2021) had resolved. At the time of the report, PRURITUS (itchiness) and HYPERSENSITIVITY (Reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received captured no new information.